HEATHER D'AMARIO: Open Payments
NPI 1912513763 · REISTERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$297 in 13 payments from 6 companies in 2025. Trend: 2023 $1,493 · 2024 $1,768 · 2025 $297
Food & beverage: $297
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $141 |
| Amgen Inc. | 2 | $46 |
| ABBVIE INC. | 2 | $41 |
| Astellas Pharma US Inc | 1 | $25 |
| SANOFI-AVENTIS U.S. LLC | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
Products named: Ozempic, Rybelsus, Veozah, EVENITY, TZIELD, UBRELVY, Wegovy, KRYSTEXXA.
Industry payments across MD — which companies pay providers there.
